Testosterone and Weight Loss

Austin Health

Status and phase: Completed; Phase 2

Conditions: Obesity in Men

Treatments: Drug: placebo; Drug: Testosterone

Study type: Interventional

Funder types: Other

Identifiers

NCT01616732

04495

Details and patient eligibility

About

The investigators hypothesise that testosterone therapy will synergize with dietary intervention to achieve weight loss. Obese men will receive diet, and be randomised to either testosterone therapy or placebo. Primary outcomes will be weight and body composition.

Enrollment: 100 patients

Sex: Male

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• BMI >30

Exclusion criteria

• contraindications to testosterone therapy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

100 participants in 2 patient groups, including a placebo group

testosterone

Active Comparator group

Description:

against placebo

Treatment:

Drug: Testosterone

placebo

Placebo Comparator group

Treatment:

Drug: placebo